The tech entrepreneur accused of fatally stabbing CashApp founder Bob Lee in San Francisco last month was unraveling in the months before the attack as...
How far has the psychedelics medicines industry come over the past 12 months? Well, it depends on where you look. 11 investors predict a colorful, if...
The bacteria present in the intestine provide information about the quantities of fungi of the potentially disease-causing Candida genus. Among them, and...
Penny stocks under $1 to watch before next week. The post Best Penny Stocks To Buy Now? 7 Under $1 To Watch appeared first on Penny...
FSD Pharma Inc. (NASDAQ: HUGE / CSE: HUGE / FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech...
Hello, friends, and welcome to Daily Crunch, bringing you the most important startup, tech and venture capital news in a single package. Daily Crunch:...
The owner of the state's first psilocybin service center to receive a license speaks about the lengthy path to approval. The post Oregon Approves First...
The company's net loss ticked down after March labor cuts. The post Atai Life Sciences Remains Bullish on Mental Health Drug Trials Despite Cash Burn appeared...
Oregon, the first state to legalize psilocybin therapy services, continues to roll out the foundations of its new psychedelic medicine industry. Back in...
Though psychedelics are gaining mainstream support from media and patients alike, the medical institution is not as quick to voice its unwavering support....
Psychedelic drug company Compass Pathways plc (Nasdaq: CMPS) reported its financial results for the first quarter of 2023 and gave an update on recent...
Psychedelic biotech company GH Research PLC (Nasdaq: GHRS) reported financial results for the first quarter that ended March 31, 2023. The company has...
Natural products include probiotics, herbal remedies, vitamins and minerals, homeopathic medicines, traditional medicines among others The post Optimi...
In preclinical models, Lucid-MS has been shown to prevent a hallmark pathology feature of MS. The post FSD Pharma Makes Progress with MS Study appeared...
VANCOUVER – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), an end-to-end drug researcher and formulator licensed by Health Canada to produce...